ST. PAUL, Minn.--(BUSINESS WIRE)--3M
Drug Delivery Systems announced today that STADA
Arzneimittel AG has become the latest drug company to license 3M’s
patented technology directed to a matrix patch for the transdermal
delivery of the opioid pain medication fentanyl. Terms of the license
agreement were not disclosed.
The 3M Patent (EP 2158905), which was granted on March 20, 2013, enables
a transdermal drug delivery device designed to deliver a therapeutically
effective amount of fentanyl across the skin of a patient. The matrix
device is configured by incorporating fentanyl into an adhesive matrix
made of a copolymer containing alkyl acrylate and other monomers.
3M is open to licensing this technology to other interested parties.
About STADA Arzneimittel AG
STADA Arzneimittel AG is a
publicly-listed company with headquarters in Bad Vilbel, Germany. STADA
consistently focuses on a multi-pillar strategy of generics and branded
products (OTC) with an increasingly international market orientation.
The Group traditionally has a strong presence in Europe and is the only
independent generics producer in Germany. Worldwide, STADA is one of the
five leading companies in the generics industry and is represented in
more than 30 countries with approximately 50 subsidiaries. Branded
products such as Mobilat, Grippostad and Ladival are among the highest
selling in their product category in Germany. In financial year 2012,
STADA achieved Group sales of Euro 1,837.5 million, adjusted earnings
before interest, taxes, depreciation and amortization (EBITDA) of Euro
367.5 million and adjusted net income of Euro 147.9 million. As of
December 31, 2012, STADA employed 7,761 people worldwide.
About 3M Drug Delivery Systems
3M Drug Delivery Systems
partners with pharmaceutical and biotech companies to develop and
manufacture pharmaceutical products using 3M's inhalation, transdermal
or microneedle drug delivery technology. 3M offers a full range of
feasibility, development and manufacturing capabilities to help bring
products to market. Regulatory expertise, quality assurance, operations,
marketed product support and other in-house resources are available for
each step of the development and commercialization process. For more
information, please visit www.3M.com/dds
or call 1-800-643-8086.
3M captures the spark of new ideas and transforms
them into thousands of ingenious products. Our culture of creative
collaboration inspires a never-ending stream of powerful technologies
that make life better. 3M is the innovation company that never stops
inventing. With $30 billion in sales, 3M employs 88,000 people worldwide
and has operations in more than 70 countries. For more information,
or follow @3MNews on Twitter.
3M is a trademark of 3M Company.